Form 4: Rapid Micro Biosystems CFO Sells Shares for Tax

Sentiment:

Insider Transaction Report


Rapid Micro Biosystems CFO Sean M. Wirtjes sold 6,027 shares of Class A Common Stock to cover tax obligations related to restricted stock unit vesting.

Summary

  • Sean M. Wirtjes, Chief Financial Officer of Rapid Micro Biosystems, Inc. (RPID), reported a sale of Class A Common Stock.
  • The transaction involved the disposition of 6,027 shares on February 9, 2026.
  • The shares were sold at a price of $3.7827 per share.
  • The sale was an automatic transaction to cover tax obligations associated with the vesting of restricted stock units.
  • Following this transaction, Mr. Wirtjes beneficially owns 483,928 shares of Class A Common Stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a routine, non-discretionary sale by an executive to satisfy tax liabilities arising from equity compensation, rather than a discretionary investment decision.

Negatives

  • The Chief Financial Officer's direct beneficial ownership of Class A Common Stock decreased by 6,027 shares.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that sales of shares by executives to cover tax obligations upon the vesting of restricted stock units are a common and routine occurrence in the corporate world, typically not indicative of a change in management's outlook on the company's performance.

Stakeholder Impact

  • Shareholders: A minor reduction in the Chief Financial Officer's direct beneficial ownership, which is a routine consequence of equity compensation vesting and tax coverage.

Key Dates

DateDescription
02/09/2026Date of transaction (sale of Class A Common Stock)
02/10/2026Date the Form 4 was signed by the reporting person

Recommendation

hold

This Form 4 reports a routine, non-discretionary sale of shares by the CFO to cover tax obligations related to RSU vesting. Such transactions are common and generally do not signal a change in the executive's confidence in the company or its future prospects. Therefore, it provides no new information that would warrant a change in investment recommendation, suggesting a 'hold' position based solely on this filing.

Keywords

RPID, Rapid Micro Biosystems, Form 4, Insider Transaction, Stock Sale, CFO, Restricted Stock Units, Tax Obligations

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.